Modulation of Inducible Nitric Oxide Synthase Activation by Immuno-suppressive Drugs
Journal:
Current Drug Metabolism
Volume:
2
Page:
315-329
Author(s):
V. Trajkovic
Amylin Replacement With Pramlintide as an Adjunct to Insulin Therapy in Type 1 and Type 2 Diabetes Mellitus: A Physiological Approach Toward Improved Metabolic Control
Journal:
Current Pharmaceutical Design
Volume:
7
Page:
1353-1373
Author(s):
C. Weyer, D. G. Maggs, A. A. Young and O. G. Kolterman
Development of Glucagon-Like Peptide-1-Based Pharmaceuticals as Therapeutic Agents for the Treatment of Diabetes
Journal:
Current Pharmaceutical Design
Volume:
7
Page:
1399-1412
Author(s):
Daniel J. Drucker
Changes in Immune and Endocrine Systems in Scrapie-Infected Animals
Journal:
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents
Volume:
1
Page:
171-183
Author(s):
X. Ye, A. C. Scallet and R. I. Carp
G Protein-Coupled Receptor Kinase 2 - a Feedback Regulator of Gq Pathway Signalling
Journal:
Current Drug Targets - Immune, Endocrine & Metabolic Disorders
Volume:
1
Page:
139-151
Author(s):
J. Theilade, S. Haunso and S. P. Sheikh
The HCMV Chemokine Receptor US28 is a Potential Target in Vascular Disease
Journal:
Current Drug Targets - Infectious Disorders
Volume:
1
Page:
151-158
Author(s):
D. N. Streblow, S. L. Orloff and J. A. Nelson
Gene Therapy for Diabetes Mellitus
Journal:
Current Molecular Medicine
Volume:
1
Page:
325-337
Author(s):
T. Yamaoka
Hepatic Cytochrome P450 Regulation in Disease States
Journal:
Current Drug Metabolism
Volume:
2
Page:
165-183
Author(s):
Po-Yung Cheng and Edward T. Morgan
Ceruloplasmin, the Unique Multi-Copper Oxidase of Vertebrates
Journal:
Protein & Peptide Letters
Volume:
8
Page:
159-169
Author(s):
Giovanni Musci
Diabetes Mellitus-Cell Transplantation and Gene Therapy Approaches.
Journal:
Current Molecular Medicine
Volume:
1
Page:
273-286
Author(s):
Tanya Halvorsen and Fred Levine